90 related articles for article (PubMed ID: 12020241)
1. Raynaud phenomenon and Behçet disease: diagnosis with technetium Tc 99m methylene diphosphonate bone scan and treatment with continuous sympathetic block.
Onder M; Ozden MG; Aksakal AB; Akçali D; Babacan A; Atasever T
Arch Dermatol; 2002 May; 138(5):698-9. PubMed ID: 12020241
[No Abstract] [Full Text] [Related]
2. Evaluation of finger blood flow with Tc-99m MDP (methylene diphosphonate).
Bang SH; Oh YS; Park HJ; Lee TK; Yang JS; Lee SM; Min KW; Park W
Korean J Intern Med; 1992 Jul; 7(2):94-101. PubMed ID: 1306078
[TBL] [Abstract][Full Text] [Related]
3. Bone scintigraphy of Raynaud's syndrome secondary to fibromuscular dysplasia.
Matthies A; Meyka S; Biersack HJ; Reinhardt M
Clin Nucl Med; 2004 May; 29(5):316-7. PubMed ID: 15069332
[No Abstract] [Full Text] [Related]
4. The usefulness of Tc-99m-MDP bone scintigraphy in detection of articular involvement of Behçet's disease.
Sahin M; Yildiz M; Tunc SE; Cerci S; Suslu H; Cure E; Kutlucan A
Ann Nucl Med; 2006 Dec; 20(10):649-53. PubMed ID: 17385302
[TBL] [Abstract][Full Text] [Related]
5. Osteonecrosis in Behcet's disease seen on bone scintigraphy.
Yapar Z; Kibar M; Soy M; Ozbek S
Clin Nucl Med; 2001 Mar; 26(3):267-8. PubMed ID: 11245135
[No Abstract] [Full Text] [Related]
6. Predictive value of bone scintigraphy for the detection of joint involvement in Behçet's disease: Dermatologists' perspectives.
Seo J; Lee M; Choi MJ; Zheng Z; Cho A; Bang D; Kim DY
Eur J Dermatol; 2015; 25(5):477-82. PubMed ID: 26394693
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m methylene diphosphonate scintigraphy of relapsing polychondritis.
Kao CH; Liao SQ; Wang SJ
Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Sep; 7(9):489-91. PubMed ID: 1779443
[TBL] [Abstract][Full Text] [Related]
8. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications.
Tan KF; Chang CH
Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712
[No Abstract] [Full Text] [Related]
9. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
10. Technetium Tc 99m medronate bone scanning in rhabdomyolysis.
Frymoyer PA; Giammarco R; Farrar FM; Schroeder ET
Arch Intern Med; 1985 Nov; 145(11):1991-5. PubMed ID: 4062449
[TBL] [Abstract][Full Text] [Related]
11. Technetium 99m-methylene diphosphonate bone scans in children with reflex neurovascular dystrophy.
Laxer RM; Allen RC; Malleson PN; Morrison RT; Petty RE
J Pediatr; 1985 Mar; 106(3):437-40. PubMed ID: 3156227
[TBL] [Abstract][Full Text] [Related]
12. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
Armas R; Neumann R; Goldsmith SJ
J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
[TBL] [Abstract][Full Text] [Related]
13. [Algodystrophy in adults with hypofixation during bone scintigraphy using technetium 99m-methylene diphosphonate].
Sereni D; Khalifa P; Richard B; Doury P; Cremer GA
Rev Rhum Mal Osteoartic; 1987 Nov; 54(11):767-9. PubMed ID: 3423721
[No Abstract] [Full Text] [Related]
14. Malignant fibrous histiocytoma: etiology for a cold defect on technetium-99m-methylene diphosphonate bone scan.
Sanders TG; Wilf LH; Northup HM
J Nucl Med; 1990 Jun; 31(6):1104-5. PubMed ID: 2161452
[TBL] [Abstract][Full Text] [Related]
15. Visualizing the effect of pentoxyphyllin infusion therapy on the circulation of the hand by Tc-99m DPTA scintigraphy.
Garai I; Csiki Z; Szücs G; Varga J; Galuska L
Clin Nucl Med; 2003 Jul; 28(7):611-2. PubMed ID: 12819427
[No Abstract] [Full Text] [Related]
16. Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication.
Rudd TG; Allen DR; Smith FD
J Nucl Med; 1979 Aug; 20(8):821-6. PubMed ID: 120422
[TBL] [Abstract][Full Text] [Related]
17. Transient myocardial uptake of Tc-99m methylene diphosphonate in a patient with amyloidosis.
Kinney EL; Chandarlapaty SK
Am J Med Sci; 1988 Dec; 296(6):413-6. PubMed ID: 3213841
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of Raynaud's phenomenon by (99m)Tc-hydroxymethylene diphosphonate digital blood flow scintigraphy after one-hand chilling.
Kwon SR; Lim MJ; Park SG; Hyun IY; Park W
J Rheumatol; 2009 Aug; 36(8):1663-70. PubMed ID: 19531744
[TBL] [Abstract][Full Text] [Related]
19. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
Littlefield JL; Rudd TG
J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
[TBL] [Abstract][Full Text] [Related]
20. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.
Lee VW; Caldarone AG; Falk RH; Rubinow A; Cohen AS
Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
